Resource type
Date created
2020-10-27
Authors/Contributors
Author: Catherine, Nicole
Author: Boyle, Michael H.
Author: Zheng, Yufei
Author: McCandless, Lawrence
Author: Xie, Hui
Author: Lever, Rosemary
Author: Sheehan, Debbie
Author: Gonzalez, Andrea
Author: Jack, Susan M.
Author: Gafni, Amiram
Author: Tonmyr, Lil
Author: Marcellus, Lenora
Author: Varcoe, Colleen
Author: Cullen, Ange
Author: Hjertaas, Kathleen
Author: Riebe, Caitlin
Author: Rikert, Nikolina
Author: Sunthoram, Ashvini
Author: Barr, Ronald
Author: MacMillan, Harriet
Author: Waddell, Charlotte
Abstract
Background: Nurse-Family Partnership (NFP) involves public health nurses providing frequent home visits from early pregnancy until children reach age 2 years, focusing on first-time parents experiencing socioeconomic disadvantage. Our aim was to evaluate NFP’s effectiveness in improving child and maternal health.
Methods: We conducted an analysis of prenatal secondary outcomes in an ongoing randomized controlled trial in British Columbia; the data used in this analysis were collected from January 2014 to May 2017. Participants were pregnant girls and women aged 14–24 years who were preparing to parent for the first time and experiencing socioeconomic disadvantage. They were randomly allocated 1:1 to the intervention (NFP plus existing services) or control group (existing services). Prespecified prenatal secondary outcome indicators were changes in use of nicotine cigarettes and alcohol use by 34–36-weeks’ gestation. We also report on prespecified exploratory cannabis and street drug use measures. We used mixed-effect models for longitudinal and clustered data to estimate intervention effects. Analyses were by intention to treat.
Results: The median gestational age at baseline for the 739 participants (368 participants in the intervention group, 371 in the comparison group) was 20 weeks, 6 days. By 34–36 weeks’ gestation, NFP significantly reduced cigarette counts (over the past 2 d) (difference in changes [DIC] of count –1.6, 95% confidence interval [CI] –6.4 to –1.3) in those who smoked. NFP also significantly reduced rates of prenatal cannabis use (DIC –6.4, 95% CI –17.0 to –1.7), but not rates of street drug or “any” substance use. While we observed decreased rates of cigarette and alcohol use in both groups (DIC of proportions –2.8, 95% CI –15.3 to 0.6; DIC –0.5, 95% CI –8.7 to 1.8, respectively), these changes were not statistically significant.
Interpretation: We found no evidence that NFP was effective in reducing rates of prenatal cigarette and alcohol use; however, it led to reduced prenatal cannabis use, and in smokers it led to modest reductions in cigarette use. NFP may therefore hold promise for reducing some types of prenatal substance use in disadvantaged populations. Trial registration: ClinicalTrials.gov, no. NCT01672060.
Methods: We conducted an analysis of prenatal secondary outcomes in an ongoing randomized controlled trial in British Columbia; the data used in this analysis were collected from January 2014 to May 2017. Participants were pregnant girls and women aged 14–24 years who were preparing to parent for the first time and experiencing socioeconomic disadvantage. They were randomly allocated 1:1 to the intervention (NFP plus existing services) or control group (existing services). Prespecified prenatal secondary outcome indicators were changes in use of nicotine cigarettes and alcohol use by 34–36-weeks’ gestation. We also report on prespecified exploratory cannabis and street drug use measures. We used mixed-effect models for longitudinal and clustered data to estimate intervention effects. Analyses were by intention to treat.
Results: The median gestational age at baseline for the 739 participants (368 participants in the intervention group, 371 in the comparison group) was 20 weeks, 6 days. By 34–36 weeks’ gestation, NFP significantly reduced cigarette counts (over the past 2 d) (difference in changes [DIC] of count –1.6, 95% confidence interval [CI] –6.4 to –1.3) in those who smoked. NFP also significantly reduced rates of prenatal cannabis use (DIC –6.4, 95% CI –17.0 to –1.7), but not rates of street drug or “any” substance use. While we observed decreased rates of cigarette and alcohol use in both groups (DIC of proportions –2.8, 95% CI –15.3 to 0.6; DIC –0.5, 95% CI –8.7 to 1.8, respectively), these changes were not statistically significant.
Interpretation: We found no evidence that NFP was effective in reducing rates of prenatal cigarette and alcohol use; however, it led to reduced prenatal cannabis use, and in smokers it led to modest reductions in cigarette use. NFP may therefore hold promise for reducing some types of prenatal substance use in disadvantaged populations. Trial registration: ClinicalTrials.gov, no. NCT01672060.
Document
Identifier
DOI: 10.9778/cmajo.20200063
Publication details
Publication title
CMAJ Open
Document title
Nurse home visiting and prenatal substance use in a socioeconomically disadvantaged population in British Columbia: Analysis of prenatal secondary outcomes in an ongoing randomized controlled trial
Publisher
Canadian Medical Association
Date
2020-10-27
Volume
8
Issue
4
First page
E667
Last page
E675
Publisher DOI
10.9778/cmajo.20200063
Published article URL
Copyright statement
Copyright is held by the publisher with many rights continuing to also be held by the author(s).
Scholarly level
Peer reviewed?
Yes
Funder
Funder: Fraser Health
Funder: Interior Health
Funder: Vancouver Coastal Health
Funder: Djavad Mowafaghian Foundation
Member of collection
Download file | Size |
---|---|
NurseHomeVisitingPrenatalSubstanceUse_0.pdf | 652.19 KB |